Skip to main content
. 2020 Jun 4;33:100594. doi: 10.1016/j.gore.2020.100594

Fig. 1.

Fig. 1

Progression-free survival and overall survival since starting trabectedin treatment, in all patients and considering the line of treatment in advanced disease.